Serina Therapeutics Inc./$SER
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Ticker
$SER
Sector
Primary listing
AMEX
Industry
Biotechnology
Headquarters
Employees
13
ISIN
US81751A1088
Website
SER Metrics
BasicAdvanced
$59M
-
-$0.10
-
-
Price and volume
Market cap
$59M
52-week high
$6.61
52-week low
$4.10
Average daily volume
17K
Financial strength
Current ratio
2.446
Quick ratio
1.814
Long term debt to equity
14.561
Total debt to equity
26.427
Interest coverage (TTM)
-56.20%
Profitability
EBITDA (TTM)
-18.923
Gross margin (TTM)
-18,184.31%
Net profit margin (TTM)
-1,841.18%
Operating margin (TTM)
-37,468.63%
Management effectiveness
Return on assets (TTM)
-135.82%
Return on equity (TTM)
73.75%
Valuation
Price to revenue (TTM)
1,059.957
Price to book
34.68
Price to tangible book (TTM)
34.68
Price to free cash flow (TTM)
-2.718
Free cash flow yield (TTM)
-36.79%
Free cash flow per share (TTM)
-218.56%
Growth
Revenue change (TTM)
-98.37%
Earnings per share change (TTM)
-97.85%
SER News
AllArticlesVideos
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewsWire·3 days ago
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
GlobeNewsWire·2 weeks ago
UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Serina Therapeutics Inc. stock?
Serina Therapeutics Inc. (SER) has a market cap of $59M as of July 04, 2025.
What is the P/E ratio for Serina Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Serina Therapeutics Inc. (SER) stock is 0 as of July 04, 2025.
Does Serina Therapeutics Inc. stock pay dividends?
No, Serina Therapeutics Inc. (SER) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Serina Therapeutics Inc. dividend payment date?
Serina Therapeutics Inc. (SER) stock does not pay dividends to its shareholders.
What is the beta indicator for Serina Therapeutics Inc.?
Serina Therapeutics Inc. (SER) does not currently have a Beta indicator.